Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial by James P. Sheppard, Mark Lown, Jenni Burt, Gary A. Ford, F. D. Richard Hobbs, Paul Little, Jonathan Mant, Rupert A. Payne, Richard J. McManus, On behalf of the OPTiMISE Investigators

Get full text

Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients aged ≥ 80 years with hypertension: the OPTiMISE randomized clinical t... by Sheppard, JP, Burt, J, Lown, M, Temple, E, Lowe, R, Fraser, R, Allen, J, Ford, GA, Heneghan, C, Hobbs, FDR, Jowett, S, Kodabuckus, S, Little, P, Mant, J, Mollison, J, Payne, RA, Williams, M, Yu, L-M, McManus, RJ

Other Authors: “…The OPTiMISE Investigators…”

Cost-effectiveness of antihypertensive deprescribing in primary care: a Markov modelling study using data from the OPTiMISE trial by Jowett, S, Kodabuckus, S, Ford, GA, Hobbs, FDR, Lown, M, Mant, J, Payne, R, McManus, RJ, Sheppard, JP

Other Authors: “…OPTiMISE investigators…”

Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial by Sheppard, JP, Temple, E, Wang, A, Smith, A, Pollock, S, Ford, GA, Hobbs, FDR, Kenealy, N, Little, P, Lown, M, de Lusignan, S, Mant, J, McCartney, D, Payne, RA, Williams, M, Yu, L-M, McManus, RJ

Other Authors: “…OPTiMISE Investigators…”